Loading...

CVS Health Corporation

CVSNYSE
Healthcare
Medical - Healthcare Plans
$59.64
$-1.06(-1.75%)

CVS Health Corporation (CVS) Stock Overview

Explore CVS Health Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.4/100

Key Financials

Market Cap75.4B
P/E Ratio14.22
EPS (TTM)$4.19
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$63.98
1 Month$62.41
3 Months$52.96
1 Year Target$51.64

CVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CVS Health Corporation (CVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $51.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.22 and a market capitalization of 75.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;